Replies to post #16769 on Momenta Pharmaceuticals, Inc. (MNTA)

[rwwine]

Very much appreciate your mindset and unemotional take on this situation. I agree with you in that Teva will benefit from this misstep. I've professionally been on Quality Audits both by the FDA, customer audits (Pharma type) and third party. What really bothers me is the sloppiness by MNTA for not riding PFE all the way through and making darn sure something like this would not happen. Clearly in my opinion, MNTA QA team dropped the ball and now the company will pay the price on lost revenue. Such a shame.....